Inside NIA Archives: Alzheimer's Disease
Identifying the genes involved in Alzheimer’s disease and related dementias is of course no easy task. From among the thousands of gene candidates in the human genome, we need to determine... Read More
Every week, the NIA blog brings you important information on funding, grants, scientific resources, and other topics of interest to researchers. Have a question you’d like us to cover? Let us... Read More
Determining the best way forward in Alzheimer’s disease research is as challenging and complicated as the disorder itself.
My dedicated staff in the Division of Neuroscience oversees and... Read More
Are you studying the genetics of late-onset Alzheimer’s disease? Did you know that the Alzheimer’s disease research community has a database that gives you access to a broad range of... Read More
International collaboration is vital to advancing Alzheimer’s disease research on multiple fronts, from genetics to biomarkers to translational research.
Just weeks ago, at the Alzheimer’... Read More
Do you struggle to recruit older participants into your research? Researchers tell us that recruiting older adults—especially from underrepresented groups—is challenging, while the need... Read More
With apologies to Dickens and to Chaplin…
It is the best of times.
When the dust cleared on our budget this year, the NIA was blessed with a 12.5%, $130 million increase over fiscal year... Read More
Last month, the NIA got good news about our budget for fiscal year 2014: $130 million more than last year. We are grateful for this increase. It means that this year there will be more funding than... Read More
Optimism and pessimism compete with each other as we contemplate the future for research and research funding. The prospects for important breakthroughs in NIA’s primary areas of medical... Read More
Did you know that there’s a new way to search for funded research projects in Alzheimer’s disease?
You can find out who is doing work in your area of interest in the US and other... Read More
It was the best of times, it was the worst of times... --Charles Dickens
These words sum up the state of Alzheimer’s disease (AD) research, specifically therapy development, over the last few... Read More